HealthLynked Corp.
HLYK
$3.50
$0.030.87%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -51.84% | -30.60% | -25.62% | -23.28% | -31.49% |
| Total Other Revenue | 128.66% | -95.37% | -13.41% | 26.32% | -420.41% |
| Total Revenue | -49.88% | -34.16% | -25.49% | -22.90% | -33.54% |
| Cost of Revenue | -65.82% | -60.49% | -44.04% | -31.53% | -27.51% |
| Gross Profit | -4.65% | 82.52% | 13.45% | -9.35% | -46.22% |
| SG&A Expenses | -16.95% | -20.75% | -47.56% | -37.02% | -40.52% |
| Depreciation & Amortization | -6.69% | -75.57% | -68.11% | -67.63% | -67.84% |
| Other Operating Expenses | -39.02% | -40.74% | -36.43% | -34.94% | -17.28% |
| Total Operating Expenses | -38.50% | -40.60% | -45.18% | -36.23% | -33.07% |
| Operating Income | 29.10% | 44.56% | 59.67% | 47.59% | 32.67% |
| Income Before Tax | 45.01% | 56.83% | 54.49% | 24.27% | 4.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 45.01% | 56.83% | 54.49% | 24.27% | 4.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.01% | 56.83% | 54.49% | 24.27% | 4.32% |
| EBIT | 29.10% | 44.56% | 59.67% | 47.59% | 32.67% |
| EBITDA | 29.97% | 45.09% | 56.46% | 48.69% | 33.36% |
| EPS Basic | 46.01% | 57.03% | 54.53% | 24.68% | 8.70% |
| Normalized Basic EPS | 53.14% | 44.47% | 51.34% | 15.75% | -4.41% |
| EPS Diluted | 45.30% | 57.04% | 75.14% | 24.68% | 7.91% |
| Normalized Diluted EPS | 53.14% | 44.47% | 51.34% | 15.75% | -4.41% |
| Average Basic Shares Outstanding | 1.87% | 0.46% | 0.06% | 0.52% | 4.79% |
| Average Diluted Shares Outstanding | 1.87% | 0.46% | 0.06% | 0.52% | 4.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |